114 related articles for article (PubMed ID: 38682183)
1.
Ou Y; Luo H; Zhang Q; Du T; Liu R; Wang D; Chen J; Dong M; Wang Y; Yang Z; Wang X
Front Biosci (Landmark Ed); 2024 Apr; 29(4):144. PubMed ID: 38682183
[TBL] [Abstract][Full Text] [Related]
2. Ubiquitin-like modifier activating enzyme 2 promotes cell migration and invasion through Wnt/β-catenin signaling in gastric cancer.
Li J; Sun X; He P; Liu WQ; Zou YB; Wang Q; Meng XW
World J Gastroenterol; 2018 Nov; 24(42):4773-4786. PubMed ID: 30479464
[TBL] [Abstract][Full Text] [Related]
3. SUMOylation of RALY promotes vasculogenic mimicry in glioma cells via the FOXD1/DKK1 pathway.
Cao S; Wang D; Wang P; Liu Y; Dong W; Ruan X; Liu L; Xue Y; E T; Lin H; Liu X
Cell Biol Toxicol; 2023 Dec; 39(6):3323-3340. PubMed ID: 37906341
[TBL] [Abstract][Full Text] [Related]
4. Increased SUMO-activating enzyme SAE1/UBA2 promotes glycolysis and pathogenic behavior of rheumatoid fibroblast-like synoviocytes.
Wang C; Xiao Y; Lao M; Wang J; Xu S; Li R; Xu X; Kuang Y; Shi M; Zou Y; Wang Q; Liang L; Zheng SG; Xu H
JCI Insight; 2020 Sep; 5(18):. PubMed ID: 32938830
[TBL] [Abstract][Full Text] [Related]
5. Identifying UBA2 as a proliferation and cell cycle regulator in lung cancer A549 cells.
Jiang B; Fan X; Zhang D; Liu H; Fan C
J Cell Biochem; 2019 Aug; 120(8):12752-12761. PubMed ID: 30848500
[TBL] [Abstract][Full Text] [Related]
6. MCM10 as a novel prognostic biomarker and its relevance to immune infiltration in gliomas.
Tian QS; Zhang Q; Huang W
Technol Health Care; 2023; 31(4):1301-1317. PubMed ID: 36872806
[TBL] [Abstract][Full Text] [Related]
7. UBA2 promotes proliferation of colorectal cancer.
He P; Sun X; Cheng HJ; Zou YB; Wang Q; Zhou CL; Liu WQ; Hao YM; Meng XW
Mol Med Rep; 2018 Dec; 18(6):5552-5562. PubMed ID: 30387828
[TBL] [Abstract][Full Text] [Related]
8. The prognosis, chemotherapy and immunotherapy efficacy of the SUMOylation pathway signature and the role of UBA2 in lung adenocarcinoma.
Yu L; Lin N; Ye Y; Zhuang H; Zou S; Song Y; Chen X; Wang Q
Aging (Albany NY); 2024 Feb; 16(5):4378-4395. PubMed ID: 38407971
[TBL] [Abstract][Full Text] [Related]
9. Knockdown of Uba2 inhibits colorectal cancer cell invasion and migration through downregulation of the Wnt/β-catenin signaling pathway.
Cheng H; Sun X; Li J; He P; Liu W; Meng X
J Cell Biochem; 2018 Aug; 119(8):6914-6925. PubMed ID: 29744931
[TBL] [Abstract][Full Text] [Related]
10. MELK is a prognostic biomarker and correlated with immune infiltration in glioma.
Yang H; Zhou H; Wang G; Tian L; Li H; Zhang Y; Xue X
Front Neurol; 2022; 13():977180. PubMed ID: 36353126
[TBL] [Abstract][Full Text] [Related]
11. UBA2 promotes the progression of renal cell carcinoma by suppressing the p53 signaling.
Du X; Shi J
Ir J Med Sci; 2022 Aug; 191(4):1555-1560. PubMed ID: 34467471
[TBL] [Abstract][Full Text] [Related]
12. Crystal structure of UBA2(ufd)-Ubc9: insights into E1-E2 interactions in Sumo pathways.
Wang J; Taherbhoy AM; Hunt HW; Seyedin SN; Miller DW; Miller DJ; Huang DT; Schulman BA
PLoS One; 2010 Dec; 5(12):e15805. PubMed ID: 21209884
[TBL] [Abstract][Full Text] [Related]
13. High-yield expression of mouse Aos1-Uba2-fusion SUMO-activating enzyme, mAU, in a baculovirus-insect cell system.
Kanemaru A; Saitoh H
Biosci Biotechnol Biochem; 2013; 77(7):1575-8. PubMed ID: 23832333
[TBL] [Abstract][Full Text] [Related]
14. Hepcidin is upregulated and is a potential therapeutic target associated with immunity in glioma.
Dong T; Zhang B; Zhang R; Wang C; Liu X; Wang F; Hao N; Tan K; Chang YZ
Front Oncol; 2022; 12():963096. PubMed ID: 36237302
[TBL] [Abstract][Full Text] [Related]
15. Knockdown of ubiquitin-like modifier-activating enzyme 2 promotes apoptosis of clear cell renal cell carcinoma cells.
Zhang G; Zou J; Shi J; Qian B; Qiu K; Liu Q; Xie T; He Z; Xu H; Liao Y; Wu Y; Li Y; Xiao G; Yuan Y; Xiao R; Wu G; Zou X
Cell Death Dis; 2021 Nov; 12(11):1067. PubMed ID: 34753901
[TBL] [Abstract][Full Text] [Related]
16. SAE1 promotes human glioma progression through activating AKT SUMOylation-mediated signaling pathways.
Yang Y; Liang Z; Xia Z; Wang X; Ma Y; Sheng Z; Gu Q; Shen G; Zhou L; Zhu H; Xu N; Liang S
Cell Commun Signal; 2019 Jul; 17(1):82. PubMed ID: 31345225
[TBL] [Abstract][Full Text] [Related]
17. Construction of a mouse Aos1-Uba2 chimeric SUMO-E1 enzyme, mAU, and its expression in baculovirus-insect cells.
Nakayama T; Yuasa E; Kanemaru A; Saito M; Saitoh H
Bioengineered; 2014; 5(2):133-7. PubMed ID: 24637489
[TBL] [Abstract][Full Text] [Related]
18. Clinical Value of TXNDC12 Combined With IDH and 1p19q as Biomarkers for Prognosis of Glioma.
Wang X; Yang Q; Liu N; Bian Q; Gao M; Hou X
Pathol Oncol Res; 2021; 27():1609825. PubMed ID: 34629960
[No Abstract] [Full Text] [Related]
19. Ang II Promotes SUMO2/3 Modification of RhoGDI1 Through Aos1 and Uba2 Subunits, and then Regulates RhoGDI1 Stability and Cell Proliferation.
Qi Y; Guan H; Liang X; Sun J; Yao W
Cardiovasc Drugs Ther; 2021 Aug; 35(4):769-773. PubMed ID: 33891248
[TBL] [Abstract][Full Text] [Related]
20. ITGB2 as a prognostic indicator and a predictive marker for immunotherapy in gliomas.
Xu H; Zhang A; Han X; Li Y; Zhang Z; Song L; Wang W; Lou M
Cancer Immunol Immunother; 2022 Mar; 71(3):645-660. PubMed ID: 34313821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
